Table of Contents

• 1.1 List of Tables 4
• 1.2 List of Figures 6

2 Introduction 7

• 2.1 Optical Coherence Tomography (OCT) Overview 7

3 Products under Development 8

• 3.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 8
• 3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory 9
• 3.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path 10
• 3.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date 11
• 3.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials 12

4 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies 13

• 4.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development 13
• 4.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development 14

5 Optical Coherence Tomography (OCT) Companies and Product Overview 15

• 5.1 Canon USA Inc Company Overview 15
  • 5.1.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview 15
• 5.2 Carl Zeiss Meditec AG Company Overview 16
  • 5.2.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview 16
• 5.3 Compact Imaging Inc. Company Overview 17
  • 5.3.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
• 5.4 Conavi Medical Inc. Company Overview 18
  • 5.4.1 Conavi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
• 5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview 19
  • 5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview 19
• 5.6 Duke University Company Overview 20
  • 5.6.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.7 George Washington University Company Overview 23
  • 5.7.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.8 Haag-Streit AG Company Overview 24
  • 5.8.1 Haag-Streit AG Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.9 Heidelberg Engineering GmbH Company Overview 25
  • 5.9.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.10 Leica Microsystems GmbH Company Overview 27
  • 5.10.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.11 Moorfields Eye Hospital NHS Foundation Trust Company Overview 29
  • 5.11.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.12 Nippon Telegraph and Telephone Corp Company Overview 32
  • 5.12.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.13 Notal Vision Inc Company Overview 33
  • 5.13.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.14 OptoQuest Company Overview 37
  • 5.14.1 OptoQuest Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.15 Optos Plc Company Overview 38
  • 5.15.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 38
• 5.16 Optovue Inc Company Overview 41
  • 5.16.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview 41
• 5.17 Rowiak GmbH Company Overview 42
  • 5.17.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview 42
• 5.18 Sinoora Inc. Company Overview 43
  • 5.18.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.19 University of California Berkeley Company Overview 44
  • 5.19.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.20 University of Illinois at Chicago Company Overview 45
  • 5.20.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview 45
• 5.21 University of Liverpool Company Overview 46
  • 5.21.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview 46
• 5.22 University of Pittsburgh Company Overview 47
  • 5.22.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 47
• 5.23 University of Rochester Company Overview 48
  • 5.23.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 48
• 5.24 University of Texas at Austin Company Overview 49
  • 5.24.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 49

6 Optical Coherence Tomography (OCT)- Recent Developments 50

• 6.1 Oct 12, 2019: ZEISS showcases next-level eye care digitalization at AAO 2019 50
• 6.2 Oct 09, 2019: Canon U.S.A. to showcase eyecare solutions At American Academy of Ophthalmology 2019 Meeting 52
• 6.3 Oct 09, 2019: Topcon to attend American Academy of Ophthalmology 2019 Meeting 53
• 6.4 Sep 17, 2019: Canon Xephilio OCT-A1 Optical Coherence Tomography Device receives FDA 510(k) clearance 53
• 6.5 Sep 16, 2019: Ping an energizes Smart Healthcare with technology, Healthcare Ecosystem to be a future highlight 54

7 Appendix 75

• 7.1 Methodology 75
• 7.2 About GlobalData 78
• 7.3 Contact Us 78

Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Optical Coherence Tomography (OCT) - Medical Devices Pipeline Assessment, 2019" provides an overview of Optical Coherence Tomography (OCT) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Optical Coherence Tomography (OCT) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Optical Coherence Tomography (OCT) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date